Patheon acquires Gallus BioPharmaceuticals

The contract development and manufacturing organization (CDMO), Patheon has acquired Gallus Biopharmaceuticals, which has two mammalian cell culture facilities in the US. In particular, the St. Louis, Missouri plant, is a site that has served some very big pharmaceutical companies. It also uses industrial stainless steel and single-use equipment. Patheon may look at additional acquisitions in the future but for the time being will look fully integrating Gallus.

Previous articleShell fits last module for Quest project
Next articleTecninox’s butt weld fittings approved by Petrobras
Stainless Steel World Americas is part of the KCI Group of Companies. We are a leading knowledge, communication and information company connecting business-to-business professionals by building and sustaining global communities, solving their information needs and helping them to develop their professional life and friendships.